Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results.
NPJ Vaccines. 2022 Sep 24;7(1):111. doi: 10.1038/s41541-022-00531-8.
NPJ Vaccines. 2022.
PMID: 36153335
Free PMC article.